Neel A. Shah, Ph.D.
Affiliations: | 2012 | Pharmaceutical Systems and Policy | West Virginia University, Morgantown, WV, United States |
Area:
Epidemiology, Pharmacy, Public HealthGoogle:
"Neel Shah"Cross-listing: PHTree
Parents
Sign in to add mentor| Suresh Madhavan | grad student | 2012 | West Virginia University | |
| (Impact of Diabetes on Colorectal Cancer Outcomes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Averin A, Silvia A, Lamerato L, et al. (2020) Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer |
| Richert-Boe K, Lamerato L, Lyman GH, et al. (2019) Effectiveness of Prophylaxis with Granulocyte Colony-Stimulating Factor Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice Blood. 134: 4688-4688 |
| Lyman GH, Richert-Boe K, Lamerato L, et al. (2019) Predictors of Febrile Neutropenia Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice Blood. 134: 5854-5854 |
| Bonafede M, Sapra S, Shah N, et al. (2018) Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States. Headache |
| Bonafede M, Cai Q, Cappell K, et al. (2017) Factors Associated with Direct Health Care Costs Among Patients with Migraine. Journal of Managed Care & Specialty Pharmacy. 23: 1169-1176 |
| Gu T, Shah N, Deshpande G, et al. (2016) Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study. Drugs - Real World Outcomes |
| Gu T, Deshpande G, Tang D, et al. (2016) one-year biologic cost per patient with psoriatic diseases in a managed care population : 3564 Journal of the American Academy of Dermatology. 74 |
| Sauer BC, Teng CC, He T, et al. (2015) Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis. Journal of Medical Economics. 1-34 |
| Wu N, Bhurke S, Shah N, et al. (2015) Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context. Clinicoeconomics and Outcomes Research : Ceor. 7: 257-66 |
| Bonafede M, Johnson BH, Princic N, et al. (2015) Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis. Journal of Medical Economics. 18: 376-89 |